What SpaceX and its record IPO have riding on the new race to the moon

SpaceX is preparing a potential summer IPO that could raise up to $75 billion and value the company as high as $1.75 trillion. PitchBook estimates SpaceX earned $7.5 billion profit on nearly $16 billion revenue last year and projects growth to as much as $60 billion profit and $150 billion revenue by 2040, driven by Starlink, launch services and nascent satellite offerings. The company’s prospects are reinforced by NASA’s shift toward greater Starship reliance under Artemis, but material execution risks remain (Starship test failures, on-orbit refueling, and ambitious AI/data-center and manufacturing plans). Investors should weigh large upside from sector leadership against substantial technological and timeline uncertainty.

Analysis

A potential mega-capital raise from a dominant launch/infra platform will restructure bargaining power across aerospace supply chains: vendors that can scale composite tanks, high-thrust engines, orbital refueling hardware and low-latency avionics stand to win multi-year, high-margin programs while legacy prime integrators with fixed-cost SLS-style programs will see margin pressure. Expect multi-year acceleration in capex for chip fabs, power electronics and thermal management as investors flow capital into orbital compute and high-performance edge AI — this reallocates demand away from commodity cloud capex toward specialized space-qualified hardware suppliers.

Second-order market effects include lower per-launch insurance and unit launch pricing as cadence rises, which compresses barriers to entry for new satellite-native business models (comms, sensors, orbital compute). That dynamic favors agile, high-volume component suppliers and aftermarket services while creating revenue downside and program-risk exposure for defence primes tied to cost-plus, low-cadence rockets.

Key risks are execution and regulatory: orbital refueling, high-rate reusability and space-qualified AI hardware are 2–7 year technical bets with binary outcomes; a major flight failure or a string of manufacturing defects could wipe out valuation premia quickly. Near-term catalysts to monitor are public contract awards, test-flight telemetry releases, insurance-pricing moves and any IPO tranche pricing/lockup behavior — these will set sentiment and capital access windows over the next 3–12 months.

Key Decisions for Investors

• Short BA via 12-month puts (buy BA 12m 15% OTM puts) sized at 1–2% NAV: thesis is program reallocation to high-cadence commercial launch and margin compression at legacy prime programs. Target 30–45% payoff if BA EPS revision cycle turns negative; stop-loss at 20% adverse move in premium.
• Pair trade — short BA / long RKLB (Rocket Lab) equity, 3–12 month horizon: BA downside vs high-volume supplier/alternative launcher upside. Use 1:1 notional, expect asymmetric return if commercial manifest growth continues; cap loss at 15% on either leg.
• Directional TSLA exposure via 9–12 month call spread (buy TSLA 12m ATM call, sell 20% OTM call): play potential access to lower-cost, vertically integrated AI chips and robotics synergies without paying for outright upside. Risk limited to premium (R:R roughly 1:2 if TSLA rallies into spread).
• Tactical long in select space supply names (carbon-fiber, cryogenic valve makers, avionics vendors) sized 3–5% NAV, 12–36 month hold: these capture secular aftermarket and manufacturing scale benefits. Rotate to cash if program test failures or IPO pricing shock depress sector multiples >25%.